CompletedNCT00264797
Extended-release methylphenidate or placebo for teens with ADHD and substance use
About this title
Read the official source — NCT00264797Medication studyAges 13–18United States
Understand this study
Who was this study for?
Listed age limits: 13 years to 18 years.
- Listed locations
- Denver and 11 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateFebruary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 303
- Sponsor
- University of Cincinnati
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 13 Years to 18 Years
- Official registry ID
- NCT00264797
- Official title
Show the full official title
Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Denver · Jacksonville · St. Petersburg
9 more locations
- Baltimore
- Fall River
- Kansas City
- New York
- Paoli
- Pittsburgh
- North Kingstown
- Columbia
- Fort Worth
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cincinnati, a university.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate (OROS-MPH) and Methylphenidate (OROS-MPH) - Placebo.
Who was this study for?
Listed age limits: 13 years to 18 years.
